FIELD: medicine.
SUBSTANCE: inventions refer to medical diagnostics. Device includes porous part, blood moves through the hole which is located in porous part. Substance influencing the blood aggregation is added to blood. Before the hole there is prediffuser space from which blood moves to the hole, and/or after it there is postdiffuser space whereto blood moves from the hole. Substance is located in the form of coating on walls of prediffuser space and/or postdiffuser space. Method consists in applying the substance to walls, drying, and reduction. Substance from the coating with the flow created in prediffuser space, and in postdiffuser space with diffuser flow is transported from area of internal wall surface to the hole.
EFFECT: providing investigations at low substance concentration.
23 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE AND METHOD FOR AUTOMATIC RESEARCH OF BLOOD SAMPLES | 2005 |
|
RU2352939C2 |
| METHOD FOR PLATELET FUNCTION TESTING AND PLATELET FUNCTION TESTING DEVICE | 2009 |
|
RU2543652C2 |
| THROMBOCYTE ACTIVATION AND GROWTH FACTOR RELEASE USING ELECTRIC PULSES | 2015 |
|
RU2712234C2 |
| THROMBOSIS MONITOR AND METHOD OF THROMBOSIS MONITORING | 2006 |
|
RU2432577C2 |
| PREVENTION OF FORMATION AND/OR STABILISATION OF THROMBI | 2005 |
|
RU2514878C2 |
| NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN | 2001 |
|
RU2302880C2 |
| METHOD FOR ASSESSING HEMOSTATIC ACTIVITY | 2015 |
|
RU2601111C1 |
| THERAPEUTIC APAC-MOLECULE CONTAINING HEPARIN CONJUGATED WITH BLOOD PLASMA PROTEIN | 2015 |
|
RU2714112C2 |
| METHOD FOR EVALUATION OF BLOOD PLATELET FUNCTION IN WHOLE CITRATED BLOOD | 2016 |
|
RU2659421C2 |
| AGENT FOR PLATELET AGGREGATION DELAYING | 1992 |
|
RU2097039C1 |
